Tuximab

49,46088,010

Product Type Product Size Product Company
Injection 1’S Roche Pharma
SKU: N/A Category:

Description


Rituximab is a biological therapy used for rheumatoid arthritis, lupus, vasculitis and dermatomyositis

Additional information

Dose

100mg/10ml, 500mg/50ml

Reviews

There are no reviews yet.

Be the first to review “Tuximab”

Your email address will not be published. Required fields are marked *

Quick Comparison

SettingsTuximab removeAvastin 400mg/16ml removeErlonib removePerjeta removeSedol removeLetrasan remove
NameTuximab removeAvastin 400mg/16ml removeErlonib removePerjeta removeSedol removeLetrasan remove
Image
SKU
Rating
Price49,46088,010137,40033,360180,0005507,609
Stock
Availability
Add to cart

Description
Product Type Product Size Product Company
Injection 1'S Roche Pharma
Product Type Product Size
Injection 1'S
Product Company
Roche Pharma
Bevacizumab 400mg/16ml
Product Type Product Size
Tablet 60'S
Product Company
Pharma Solution
Erlotinib 150mg
Product Type Product Size
Injection 1'S
Product Company
Roche Pharma
Pertuzumab 420mg/14ml
Product Type Product Size
Injection 1'S
Product Company
Helix pharma
100mg/5ml
Product Type Product Size
Tablet 30'S
Product Company
Manufacture Deva Holding / Marketed by Searle
Letrozole 2.5mg
Content" Rituximab is a biological therapy used for rheumatoid arthritis, lupus, vasculitis and dermatomyositis" Bevacizumab is a type of targeted cancer drug treatment. It is also known as Avastin. It is a treatment for a number of different cancer types.Erlotinib is an EGFR tyrosine kinase inhibitor used to treat certain small cell lung cancers or advanced metastatic pancreatic cancers." Pertuzumab is a monoclonal antibody. . Monoclonal antibodies work by attaching to proteins on or in cancer cells. Human epidermal growth factor 2 (HER2) is a protein that makes cells grow and divide.Etoposide is a podophyllotoxin derivative used to treat testicular and small cell lung tumors. Letrozole is a non-steroidal type II aromatase inhibitor. It blocks the active site, and therefore the electron transfer chain of CYP19A1. This competitive inhibition prevents the conversion of androgens to estrogen. This action leads to a reduction in uterine weight and elevated leuteinizing hormon.
WeightN/AN/AN/AN/AN/AN/A
DimensionsN/AN/AN/AN/AN/AN/A
Additional information
Dose

100mg/10ml, 500mg/50ml